Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial

The drivers of cognitive change following first-episode psychosis remain poorly understood. Evidence regarding the role of antipsychotic medication is primarily based on naturalistic studies or clinical trials without a placebo arm, making it difficult to disentangle illness from medication effects....

Descripción completa

Detalles Bibliográficos
Autores principales: Allott, Kelly, Yuen, Hok Pan, Baldwin, Lara, O’Donoghue, Brian, Fornito, Alex, Chopra, Sidhant, Nelson, Barnaby, Graham, Jessica, Kerr, Melissa J., Proffitt, Tina-Marie, Ratheesh, Aswin, Alvarez-Jimenez, Mario, Harrigan, Susy, Brown, Ellie, Thompson, Andrew D., Pantelis, Christos, Berk, Michael, McGorry, Patrick D., Francey, Shona M., Wood, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257667/
https://www.ncbi.nlm.nih.gov/pubmed/37301832
http://dx.doi.org/10.1038/s41398-023-02501-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257667/
https://www.ncbi.nlm.nih.gov/pubmed/37301832
http://dx.doi.org/10.1038/s41398-023-02501-7

Ejemplares similares